Page last updated: 2024-10-21

1-(3-chlorophenyl)piperazine and Neurotic Disorders

1-(3-chlorophenyl)piperazine has been researched along with Neurotic Disorders in 1 studies

1-(3-chlorophenyl)piperazine: supposed metabolite of TRAZODONE; RN given refers to parent cpd; structure
1-(3-chlorophenyl)piperazine : A N-arylpiperazine that is piperazine carrying a 3-chlorophenyl substituent at position 1. It is a metabolite of the antidepressant drug trazodone.

Neurotic Disorders: Disorders in which the symptoms are distressing to the individual and recognized by him or her as being unacceptable. Social relationships may be greatly affected but usually remain within acceptable limits. The disturbance is relatively enduring or recurrent without treatment.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Murphy, DL1
Lesch, KP1
Aulakh, CS1
Pigott, TA1

Reviews

1 review available for 1-(3-chlorophenyl)piperazine and Neurotic Disorders

ArticleYear
Serotonin-selective arylpiperazines with neuroendocrine, behavioral, temperature, and cardiovascular effects in humans.
    Pharmacological reviews, 1991, Volume: 43, Issue:4

    Topics: Animals; Aza Compounds; Behavior, Animal; Body Temperature; Cardiovascular System; Dementia; Humans;

1991